Literature DB >> 25308531

Autoimmunity and autoinflammation as the yin and yang of idiopathic recurrent acute pericarditis.

Luca Cantarini1, Giuseppe Lopalco2, Carlo Selmi3, Salvatore Napodano4, Gabriella De Rosa4, Francesco Caso5, Luisa Costa6, Florenzo Iannone2, Donato Rigante4.   

Abstract

Autoimmunity and autoinflammation are generally considered as mutually exclusive mechanisms of diseases but may concur to specific syndromes. Idiopathic recurrent acute pericarditis (IRAP) is defined as the recurrence of pericardial symptoms at any point following the prior cessation of acute pericarditis, and the latency is generally 6 weeks. Manifestations of pericarditis such as pericardial friction rub, electrocardiographic changes, and pericardial effusion are less frequent in the subsequent episodes compared to the index attack, and in some cases the only clinical sign is represented by a suggestive chest pain. Several autoimmune diseases may manifest with pericarditis which is often related to viral infections, while postviral pericarditis may in turn display a nonspecific autoimmune background. Similarly, autoinflammatory syndromes such as familial Mediterranean fever and tumor necrosis factor receptor-associated periodic syndrome are characterized by self-limiting pericardial symptoms. Corticosteroids are generally effective, thus supporting the autoimmune nature of IRAP, but dramatic results are obtained with interleukin-1 blocking agents in corticosteroid-dependent cases, pointing to a pathogenic role for the inflammasome. Based on these observations, we submit that IRAP represents a paradigmatic example of the putative coexistence of autoimmunity and autoinflammation: the main aim of this review is to critically discuss the hypothesis as well as the current understanding of this enigmatic clinical condition.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anakinra; Interleukin-1; Pericardial effusion; Recurrence

Mesh:

Year:  2014        PMID: 25308531     DOI: 10.1016/j.autrev.2014.10.005

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  20 in total

1.  A retrospective study of patients with adult-onset Still's disease: is pericarditis a possible predictor for biological disease-modifying anti-rheumatic drugs need?

Authors:  Francesca Dall'Ara; Micol Frassi; Angela Tincani; Paolo Airò
Journal:  Clin Rheumatol       Date:  2016-01-12       Impact factor: 2.980

2.  Quality of life impairment in Behçet's disease and relationship with disease activity: a prospective study.

Authors:  Claudia Fabiani; Antonio Vitale; Ida Orlando; Jurgen Sota; Marco Capozzoli; Rossella Franceschini; Mauro Galeazzi; Gian Marco Tosi; Bruno Frediani; Luca Cantarini
Journal:  Intern Emerg Med       Date:  2017-06-15       Impact factor: 3.397

Review 3.  The protean ocular involvement in monogenic autoinflammatory diseases: state of the art.

Authors:  Vittoria Bascherini; Carmela Granato; Giuseppe Lopalco; Giacomo Emmi; Lorenzo Vannozzi; Daniela Bacherini; Rossella Franceschini; Florenzo Iannone; Annabella Salerni; Francesco Molinaro; Mario Messina; Bruno Frediani; Carlo Selmi; Donato Rigante; Luca Cantarini
Journal:  Clin Rheumatol       Date:  2015-04-02       Impact factor: 2.980

Review 4.  Cardiovascular disease in patients with autoinflammatory syndromes.

Authors:  Rainer Hintenberger; Agnes Falkinger; Kathrin Danninger; Herwig Pieringer
Journal:  Rheumatol Int       Date:  2017-11-01       Impact factor: 2.631

5.  Treatment of Inflammatory Diseases with IL-1 Blockade.

Authors:  Charles A Dinarello
Journal:  Curr Otorhinolaryngol Rep       Date:  2018-03-07

Review 6.  Basic Characteristics of Adults with Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Adenopathy Syndrome in Comparison with the Typical Pediatric Expression of Disease.

Authors:  Marco Cattalini; Martina Soliani; Donato Rigante; Giuseppe Lopalco; Florenzo Iannone; Mauro Galeazzi; Luca Cantarini
Journal:  Mediators Inflamm       Date:  2015-08-18       Impact factor: 4.711

Review 7.  Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: premises, perils, and perspectives.

Authors:  Giuseppe Lopalco; Luca Cantarini; Antonio Vitale; Florenzo Iannone; Maria Grazia Anelli; Laura Andreozzi; Giovanni Lapadula; Mauro Galeazzi; Donato Rigante
Journal:  Mediators Inflamm       Date:  2015-02-16       Impact factor: 4.711

Review 8.  Autoinflammatory and autoimmune contributions to complex regional pain syndrome.

Authors:  J David Clark; Vivianne L Tawfik; Maral Tajerian; Wade S Kingery
Journal:  Mol Pain       Date:  2018-08-20       Impact factor: 3.395

Review 9.  Autoinflammation and autoimmunity across rheumatic and musculoskeletal diseases.

Authors:  Zoltán Szekanecz; Iain B McInnes; Georg Schett; Szilvia Szamosi; Szilvia Benkő; Gabriella Szűcs
Journal:  Nat Rev Rheumatol       Date:  2021-08-02       Impact factor: 20.543

Review 10.  The Use of IL-1 Receptor Antagonist (Anakinra) in Idiopathic Recurrent Pericarditis: A Narrative Review.

Authors:  Shankar Baskar; Allan L Klein; Andrew Zeft
Journal:  Cardiol Res Pract       Date:  2016-01-31       Impact factor: 1.866

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.